Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients - Related Studies

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

This study is ongoing, but not recruiting participants.

Study NCT00028314. Last updated on July 30, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections
		Lipodystrophy
		Wasting Disease

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection
		Wasting Syndrome

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Lipid Metabolism Disorders
		Metabolic Diseases
		Nutrition Disorders
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Skin Diseases
		Skin Diseases, Metabolic
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Abacavir sulfate
		Atazanavir/Ritonavir
		Lopinavir/Ritonavir
		Nevirapine

5	Additional drug interventions recognized in this trial
		Abacavir
		Ritonavir

6	More general drug interventions related to this trial
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antiviral Agents
		Enzyme Inhibitors
		HIV Protease Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Protease Inhibitors
		Reverse Transcriptase Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)